1. Debt Funding Deal in Progress
Tata Capital is set to extend Rs 60 crore in debt financing to Mangalore-based fish protein manufacturer Mukka Proteins, according to sources familiar with the matter. While the negotiations are still ongoing, the total funding round is expected to reach Rs 90-100 crore.
2. Funds to Boost Facility Expansion
Mukka Proteins plans to channel the funds toward enhancing its production infrastructure. This strategic move aligns with the company’s broader growth objectives as it seeks to strengthen its position in the fish protein sector.
3. Silence from Stakeholders
Neither Tata Capital nor Mukka Proteins has responded to queries regarding the funding development, as reported by YourStory.
4. A Look at Mukka Proteins' Financial Moves
Having gone public in March 2024, Mukka Proteins raised Rs 224 crore during its IPO by pricing shares at the upper limit of its price range. In October 2024, the company increased its authorized share capital from Rs 30 crore to Rs 40 crore, subject to shareholder approval. Additionally, it greenlit a preferential allotment of 1.96 crore shares to specific investors and promoter entities to secure further capital.
5. Market Performance
On Tuesday, Mukka Proteins’ shares experienced a dip, trading 2.67% lower at Rs 33.59 on the NSE.
6. Tata Capital's Broader Financial Activities
Meanwhile, Tata Capital is making significant strides in the financial markets. Earlier in the month, the company raised $400 million through the issuance of dollar bonds with a three-and-a-half-year maturity, targeting investors in Asia and Europe. This move comes as Tata Capital prepares for its $2 billion IPO.
7. Healthcare Investment Highlights
In addition, Tata Capital Healthcare Fund, the private equity arm of Tata Capital focused on the healthcare and life sciences sector, recently invested $20 million in Harsoria Healthcare.
Conclusion
Mukka Proteins’ upcoming debt funding from Tata Capital represents a pivotal step in its expansion journey. At the same time, Tata Capital’s strategic investments and fundraising activities underscore its robust positioning across diverse sectors.